SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-040345
Filing Date
2024-04-02
Accepted
2024-04-02 17:10:14
Documents
14
Period of Report
2024-04-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K stro-20240402.htm   iXBRL 8-K 44665
2 EX-1.1 stro-ex1_1.htm EX-1.1 389255
3 EX-5.1 stro-ex5_1.htm EX-5.1 19931
4 GRAPHIC img4916824_0.jpg GRAPHIC 44263
  Complete submission text file 0000950170-24-040345.txt   702418

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT stro-20240402.xsd EX-101.SCH 26371
17 EXTRACTED XBRL INSTANCE DOCUMENT stro-20240402_htm.xml XML 4527
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 24815468
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)